Researchers from ETH Zurich have developed a compound that slows the progression of Alzheimer's in mice. The key lies in protecting nerve cells by breaking a vicious cycle where a damaged enzyme accelerates the disease. For the public, this represents a potential future option to slow dementia and improve the quality of life for millions of patients.
The mechanism that breaks the vicious cycle of the damaged enzyme 🧬
The team identified that a defective enzyme triggers a process that damages neurons. The new compound acts as a shield, blocking that chain reaction. In mice, it managed to reduce the accumulation of toxic proteins and preserve cognitive function. Although human trials are still pending, the approach is novel because it attacks the root of the problem rather than just alleviating symptoms.
Mice with memory and humans with hope (and patience) 🐭
The rodents in the Swiss lab now remember mazes better, something many humans forget when looking for their keys. But before celebrating, we must wait for clinical trials. Meanwhile, the mice enjoy their moment of scientific glory, and we keep asking where we left our cell phones. At least science is advancing, even if at a rodent's pace.